Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
Integrating ID, substance use care reduces risk for readmission, death
Patients with injection drug use-associated infections were less likely to be readmitted to the hospital or die when they were treated by a clinical team that integrated infectious disease and substance use disorder care, researchers found.
HIV, HBV, HCV testing up among Medicaid enrollees, although missed opportunities remain
Testing for HIV, hepatitis B, and hepatitis C increased among U.S. Medicaid enrollees initiating treatment for opioid use disorder. However, a recent study showed approximately three-quarters of enrollees were not tested for each condition.
Log in or Sign up for Free to view tailored content for your specialty!
Current drug use does not hinder treatment of hepatitis C virus
WASHINGTON — Active IV or prescription drug use did not affect attainment of sustained virologic response when treatment adherence for hepatitis C virus was already variable, according to a poster presented at The Liver Meeting.
Study highlights 'substantial need' to provide DAA therapy to all patients with HCV
Direct-acting antiviral treatment significantly lowered the risk for mortality and liver and non-liver outcomes in patients with chronic hepatitis C virus infection, regardless of disease stage, researchers reported.
Phages, HIV cure research and more: The IDN cover stories of 2022
In 2022, the front page of Infectious Disease News mostly peered beyond COVID-19 to showcase triumphs and progress being made elsewhere in the field of infectious disease.
Non-COVID-19 FDA news you may have missed in 2022
There was plenty of FDA news this year not related to COVID-19.
‘My only regret is I cannot do it again’: Clinicians explain why they chose ID
We continue to be captivated by the stories you tell in our “Hooked on ID” series.
Hooked on ID with Jill Foster, MD
I got into the medical field to solve problems, and the field of infectious diseases exemplifies that.
Q&A: On eve of retirement from NIAID, Fauci tells Healio what’s next
At the end of this month, Anthony S. Fauci, MD, will officially step down as director of the National Institute of Allergy and Infectious Diseases, which he has led for nearly 4 decades.
Hepatologists’ role in HCV care, elimination ‘remains one of advocacy’
WASHINGTON — A leading expert in hepatology called for fellow specialists to embrace a role of education, advocacy and support as part of a proposed national hepatitis C virus elimination program presented during The Liver Meeting.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read